Bristol-Myers Squibb Co (BMY)
55.45
+1.13
(+2.08%)
USD |
NYSE |
Nov 04, 16:00
55.20
-0.25
(-0.45%)
Pre-Market: 04:23
Bristol-Myers Squibb Cash from Investing (Quarterly): -219.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -219.00M |
| June 30, 2024 | -1.319B |
| March 31, 2024 | -19.62B |
| December 31, 2023 | -1.346B |
| September 30, 2023 | -410.00M |
| June 30, 2023 | -329.00M |
| March 31, 2023 | -210.00M |
| December 31, 2022 | 1.213B |
| September 30, 2022 | -2.081B |
| June 30, 2022 | -289.00M |
| March 31, 2022 | 95.00M |
| December 31, 2021 | 401.00M |
| September 30, 2021 | -976.00M |
| June 30, 2021 | 180.00M |
| March 31, 2021 | -143.00M |
| December 31, 2020 | -11.81B |
| September 30, 2020 | -213.00M |
| June 30, 2020 | 556.00M |
| March 31, 2020 | 610.00M |
| December 31, 2019 | -12.18B |
| September 30, 2019 | 491.00M |
| June 30, 2019 | 715.00M |
| March 31, 2019 | 1.06B |
| December 31, 2018 | -1.462B |
| September 30, 2018 | -147.00M |
| Date | Value |
|---|---|
| June 30, 2018 | -348.00M |
| March 31, 2018 | -43.00M |
| December 31, 2017 | 1.019B |
| September 30, 2017 | 142.00M |
| June 30, 2017 | -1.024B |
| March 31, 2017 | -203.00M |
| December 31, 2016 | 16.00M |
| September 30, 2016 | -368.00M |
| June 30, 2016 | 406.00M |
| March 31, 2016 | 1.426B |
| December 31, 2015 | -984.00M |
| September 30, 2015 | -62.00M |
| June 30, 2015 | -1.28B |
| March 31, 2015 | 754.00M |
| December 31, 2014 | 351.00M |
| September 30, 2014 | 164.00M |
| June 30, 2014 | -1.511B |
| March 31, 2014 | 2.212B |
| December 31, 2013 | -315.00M |
| September 30, 2013 | -475.00M |
| June 30, 2013 | 57.00M |
| March 31, 2013 | 161.00M |
| December 31, 2012 | 277.00M |
| September 30, 2012 | -4.203B |
| June 30, 2012 | 226.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-19.62B
Minimum
Mar 2024
1.213B
Maximum
Dec 2022
-2.404B
Average
-254.00M
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -210.00M |
| Johnson & Johnson | -3.128B |
| Eli Lilly and Co | -4.005B |
| Merck & Co Inc | -1.069B |
| Pfizer Inc | 4.60B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.591B |
| Cash from Financing (Quarterly) | -3.852B |
| Free Cash Flow | 13.80B |
| Free Cash Flow Per Share (Quarterly) | 2.593 |
| Free Cash Flow to Equity (Quarterly) | 7.904B |
| Free Cash Flow to Firm (Quarterly) | 5.633B |
| Free Cash Flow Yield | 12.27% |